Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy

BACKGROUND: To identify whether adjuvant transarterial chemoembolization (TACE) can improve prognosis in HCC patients with a low risk of recurrence (tumor size ≤ 5 cm, single nodule, no satellites, and no microvascular or macrovascular invasions) after hepatectomy. METHODS: The data of 489 HCC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Long-Hai, Zhu, Yu-Yao, Zhou, Jia-Min, Wang, Miao, Xu, Wei-Qi, Zhang, Ti, Mao, An-Rong, Cong, Wen-Ming, Dong, Hui, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244569/
https://www.ncbi.nlm.nih.gov/pubmed/37293583
http://dx.doi.org/10.3389/fonc.2023.1104492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244569/
https://www.ncbi.nlm.nih.gov/pubmed/37293583
http://dx.doi.org/10.3389/fonc.2023.1104492

Ejemplares similares